The Prevalence of Polycystic Ovary Syndrome in a Normal Population According to the Rotterdam Criteria Versus Revised Criteria Including Anti-Mullerian Hormone

    January 2014 in “ Human Reproduction ”
    Mette Petri Lauritsen, Jens Bentzen, Anja Pinborg, Anne Loft, Julie Lyng Forman, Lea Langhoff Thuesen, Arieh Cohen, David M. Hougaard, Anders Nyboe Andersen
    Image of study
    TLDR Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.
    The 2014 study with 447 women investigated the prevalence of polycystic ovary syndrome (PCOS) using the Rotterdam criteria and proposed revised criteria including anti-Müllerian hormone (AMH). The prevalence of PCOS was 16.6% with the Rotterdam criteria, but when using AMH or antral follicle count (AFC) as markers, the prevalence decreased to 6.3% and 8.5%, respectively. Women with PCOS had higher BMI, obesity rates, hirsutism, and LH to FSH ratios, and significantly higher median serum AMH levels. The study concluded that AMH is a useful marker for PCOS and suggested that the Rotterdam criteria be revised to include age adjustments and validated AMH threshold levels to prevent overdiagnosis, especially in younger women. The study also noted potential selection bias and excluded hormonal contraceptive users.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Related Research

    1 / 1 results